Orthopediatrics Corp (KIDS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $844.67M
Last updated: Nov 17, 2026 at 4:20 PM ET
Orthopediatrics Corp (KIDS) Statistics
Orthopediatrics (KIDS) has a market cap of $844.67M and an enterprise value of $925.89M. It kept -12.83% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 9.62% above the market cap, as debt exceeds cash.
| Market Cap | $844.67M |
|---|---|
| Enterprise Value | $925.89M |
| Latest price (Nov 17, 2026) | $31.41 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 27, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.9x and 2.2x. Its year-end P/S ranged from 1.2x to 11.8x from 2017 to 2025.
| P/S Ratio | 2.9x |
|---|---|
| Forward P/S | 3.1x |
| P/B Ratio | 2.2x |
| P/TBV Ratio | 5.2x |
| P/FCF Ratio | 238.6x |
| P/OCF Ratio | 67.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 264.1x free cash flow.
| EV / Sales | 3.5x |
|---|---|
| EV / FCF | 264.1x |
Price Statistics
The stock is up 87.97% over 52 weeks and trades 23.47% above its 50-day average.
| Beta (1Y) | 0.89 |
|---|---|
| 52-Week Change | +87.97% |
| 1-Month Change | +42.58% |
| 3-Month Change | +18.53% |
| 6-Month Change | +72.30% |
| 5-Year Change | -56.62% |
| Total Return (1Y) | +87.97% |
| Total Return (3Y CAGR) | +0.21% |
| Total Return (5Y CAGR) | -12.85% |
| Return vs SPY (1Y) | +80.55% |
| Max Drawdown (1Y) | -27.20% |
| Max Drawdown (3Y) | -58.63% |
| Sharpe Ratio (1Y) | 1.31 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $25.44 |
| 200-Day Average | $20.42 |
| 52-Week Range | $14.42 to $34.53 |
| RSI (14 Days) | 60.4 |
| Average Volume (20 Days) | 442.24K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.55x current liabilities, and total debt is 0.29x shareholder equity.
| Current Ratio | 4.55x |
|---|---|
| Quick Ratio | 2.00x |
| Debt / Equity | 0.29x |
| Debt / FCF | 30.93x |
| Interest Coverage | -2.66x |
Returns and Efficiency
Return on invested capital is -5.58% over the last 12 months, against a 5-year average of -5.40%.
| Return on Equity (ROE) | -9.98% |
|---|---|
| Return on Assets (ROA) | -6.66% |
| Return on Invested Capital (ROIC) | -5.58% |
| Return on Capital Employed (ROCE) | -5.38% |
| ROE (5Y Average) | -6.91% |
| ROA (5Y Average) | -5.12% |
| ROIC (5Y Average) | -5.40% |
| Asset Turnover | 0.53x |
| Inventory Turnover | 0.50x |
| Receivables Turnover | 4.38x |
| Cash Conversion Cycle | 696 days |
Scores
KIDS has an Altman Z-Score of 2.69, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.69 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $264.14M over the last 12 months is up 16.15% from the 12 months before.
| Revenue | $264.14M |
|---|---|
| Revenue Growth (YoY) | +16.15% |
| Gross Profit | $194.84M |
| Operating Income | -$24.80M |
| Pretax Income | -$33.59M |
| Net Income | -$33.88M |
| EBITDA | -$1.76M |
| EBIT | -$24.41M |
| Reported EPS (TTM) | -$1.17 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 66.66% of the $509.09M in total assets.
| Cash and Equivalents | $17.14M |
|---|---|
| Total Debt | $98.36M |
| Net Debt | $81.22M |
| Net Debt Per Share | $3.36 |
| Working Capital | $197.61M |
| Shareholder Equity | $339.35M |
| Book Value Per Share | $14.05 |
| Tangible Book Value | $146.90M |
| Tangible Book Per Share | $6.08 |
| Total Assets | $509.09M |
| Total Liabilities | $169.74M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $9.31M of capital spending, operating cash flow left $3.18M of free cash flow.
| Operating Cash Flow | $12.49M |
|---|---|
| Capital Expenditures | $9.31M |
| Free Cash Flow | $3.18M |
| FCF Per Share | $0.12 |
| Depreciation and Amortization | $22.65M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -9.39%, against a 5-year average of -18.17%.
| Gross Margin | 73.76% |
|---|---|
| Operating Margin | -9.39% |
| Pretax Margin | -12.72% |
| Net Margin | -12.83% |
| EBITDA Margin | -0.67% |
| EBIT Margin | -9.24% |
| FCF Margin | 1.20% |
| Gross Margin (5Y Average) | 73.89% |
| Operating Margin (5Y Average) | -18.17% |
| Net Margin (5Y Average) | -12.98% |
Growth
Revenue grew 24.56% a year over 3 years.
| Revenue Growth (3Y CAGR) | +24.56% |
|---|---|
| Revenue Growth (5Y CAGR) | +27.16% |
| Book Value Per Share Growth (2Y CAGR) | -5.79% |
| Tangible Book Per Share Growth (2Y CAGR) | -14.08% |
Dividends and Yields
KIDS does not pay a dividend. Its free cash flow yield is 0.42%.
| FCF Yield | 0.42% |
|---|---|
| Shareholder Yield | 0.00% |
Analyst Forecast
Consensus estimates put revenue growth at 13.50% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +13.50% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About KIDS
What is KIDS's market cap?
Orthopediatrics has a market cap of $844.67M. Its enterprise value, which adds debt and subtracts cash, is $925.89M.
How many shares of KIDS are outstanding?
Orthopediatrics has 24.15M shares outstanding. The count is up 2.49% from a year earlier.
Does KIDS pay a dividend?
No. Orthopediatrics does not pay a dividend.
How much debt does KIDS have?
Orthopediatrics has $98.36M of total debt and $17.14M of cash and equivalents, a net debt position of $81.22M.
KIDS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation